Investing.com — President Trump is preparing to disclose a significant private sector commitment to the development of artificial intelligence infrastructure in the United States, according to a report from CBS. The investment, amounting to billions of dollars, will be aimed

Investing.com — Shares of Replimune Group, Inc. (NASDAQ: NASDAQ:REPL) surged 17% following the announcement that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for RP1, the company’s leading oncolytic immunotherapy, for advanced melanoma and

Investing.com — Citi upgraded Rtx Corp (NYSE:RTX) to “Buy” from “Neutral,” raising its price target to $153 from $132, driven by improved revenue, cash flow outlook, and progress on the GTF engine issues. Analysts highlighted rising original equipment or OE production rates,